NCT00648895View on ClinicalTrials.gov

A Study of the Effect of Nebivolol to Evaluate Its Vasodilatory Effects in Hypertensive Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

July 31, 2009

Conditions
Hypertension
Interventions
DRUG

Nebivolol

nebivolol 10mg, 20mg, 40mg daily dosage, oral administration

DRUG

Metoprolol ER (TM)

Metoprolol ER 100mg, 200mg, 400mg, daily dosage, oral administration

Trial Locations (1)

77030

Forest Investigative Site, Houston

Sponsors
All Listed Sponsors
lead

Forest Laboratories

INDUSTRY

NCT00648895 - A Study of the Effect of Nebivolol to Evaluate Its Vasodilatory Effects in Hypertensive Patients | Biotech Hunter | Biotech Hunter